Summit Therapeutics Inc.
SMMT
Classifica tra le azioni
#1684
Summit Therapeutics Inc. is a biopharmaceutical firm dedicated to discovering,... Summit Therapeutics Inc. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing therapeutic solutions, primarily targeting infectious diseases across the United States and Latin America. The company's clinical development pipeline is heavily concentrated on therapies for Clostridioides difficile infection (CDI). Its flagship product candidate, ridinilazole, is an orally administered small molecule antibiotic currently advancing through Phase III clinical trials as a treatment for CDI. Beyond its lead asset, Summit Therapeutics is also progressing SMT-738, designed to combat multidrug-resistant infections, notably carbapenem-resistant Enterobacteriaceae (CRE). Additionally, its DDS-04 series represents a potential therapeutic avenue for various infections caused by the Enterobacteriaceae family of bacteria. Established in 2003, the company maintains its headquarters in Cambridge, Massachusetts.
Prezzo delle azioni
$15.80
Ultima sincronizzazione: 2026-10-21
Capitalizzazione di mercato
$12.61B
Variazione (1 giorno)
-1.78%
Variazione (1 anno)
-17.52%
Paese
US
Scambia Summit Therapeutics Inc. (SMMT)
Categoria
Healthcare
Storico del prezzo dell'azione per Summit Therapeutics Inc. (SMMT)
Prezzo di chiusura più alto: $16.40 il 2026-10-01
Prezzo di chiusura più basso: $11.32 il 2015-03-01
Prezzo di chiusura più basso: $11.32 il 2015-03-01
Storico del prezzo dell'azione di Summit Therapeutics Inc. dal 2015 al 2026
Andamento annuale del prezzo dell'azione
| Anno | Performance |
|---|---|
| 2026 (TTM) | -6.35% |
| 2025 | -2.36% |
| 2024 | 648.94% |
| 2023 | -27.28% |
| 2022 | -16.52% |
| 2021 | -23.50% |
| 2020 | 244.19% |
| 2019 | 23.13% |
| 2018 | -88.74% |
| 2017 | 19.67% |
| 2016 | -15.67% |
| 2015 | 0.00% |
Prezzo dell'azione per aziende simili o concorrenti
| Azienda | Prezzo dell'azione | Variazione 1a% | Il paese |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $761.37 | 8.22% |
CH
|
